Chiron Capital Management’s Incyte INCY Stock Holding History

Chiron Capital Management’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-300	Closed	-$27K	–	244
2020 Q3	$27K	Buy	+300	New	+$28.9K	0.02%	203

Other funds holding INCY

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Chiron Capital Management's INCY Position: Q4 2020 in Review

Chiron Capital Management sold out of Incyte (INCY) in Q4 2020, closing a stake of 300 shares — an estimated $27K sold.

Chiron Capital Management first reported a position in INCY in Q3 2020 and held it in 1 quarter. The position peaked at $27K in Q3 2020. 511 funds tracked by Wall St. Rank hold INCY as of Q4 2020.

Chiron Capital Management reported no remaining Incyte position as of Q4 2020 after selling out during the quarter.
Chiron Capital Management sold 300 Incyte shares in Q4 2020, an estimated $27K.
Chiron Capital Management first reported a position in Incyte in Q3 2020 and held it in 1 quarter.
Chiron Capital Management's Incyte position peaked at $27K in Q3 2020.
511 funds tracked by Wall St. Rank held Incyte as of Q4 2020.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.